This article covers major advances in our understanding of anemia in patients with CKD, including newly discovered regulatory molecules, such as hepcidin, to innovative intravenous iron therapies. The use of erythropoiesis-stimulating agents (ESA) in the treatment of anemia has undergone seismic shift ...
Monday marks China's seventh Doctors' Day. Meet Chinese doctor Wen Yan who's on an aid mission to Papua New Guinea and learn about her dedicated efforts to help upgrade the medical treatment of kidney
clinically used for the treatment of T2DM. Mechanistically, PPARγ agonists can promote fatty acid-binding protein 4 (FABP4)-mediated free fatty acid (FFA) uptake and induce fatty acid synthase (FAS) expression to increase triglyceride in hepatocytes. PPARγ increases the transcription of sterol re...
Recent advances in immunotherapy with the development of immune checkpoint inhibitors (ICIs), have changed the treatment paradigm of TNBC, with new FDA approvals and many new clinical trials in progress [1,2,3]. Although current TNBC immunotherapy strategies are effective in early stage TNBC ...
Meet Chinese doctor Wen Yan who's on an aid mission to Papua New Guinea and learn about her dedicated efforts to help upgrade the medical treatment of kidney disease at the Port Moresby General Hospital. #GLOBALink You may like Tourists have fun at water park in Chongqing Chongqing East ...
Advances in data analysis and machine learning may soon enable clinicians to generate individualized chorioretinal risk scores to identify patients at risk of adverse outcomes on the basis of precise segmented OCT metrics. The advancement of multimodal functional retinal imaging has brought the previously...
Diabetic kidney disease (DKD), the most common cause of kidney failure and end-stage kidney disease worldwide, will develop in almost half of all people with type 2 diabetes. With the incidence of type 2 diabetes continuing to increase, early detection a
Several trials, reviewed herein, suggest that lowering the serum uric acid level is associated with a slowing in the rate of renal deterioration in those with chronic kidney disease. Given that there is little available in the general armamentarium to slow the rate of kidney deterioration, strong...
: chemically synthesized small-molecule drugs that make up most of the market; and more expensive, protein-based biologics. Cellular therapy has now emerged as a third contender, setting the stage for powerful new vaccines, regenerative heart medication, and major advances in cancer treatment....
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food 2023, Nutrients Chest CT-assessed comorbidities and all-cause mortality risk in COPD patients in the BODE cohort 2022, Respirology Possible mechanisms of cholesterol elevation aggravating covid-19 2021, Intern...